Sandoz Private Limited Apixaban Export Data — India (DGFT 2022–2026)

Name: Sandoz Private Limited Apixaban Export Records India — #4 Exporter, 500 Shipments, $15.6M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Apixaban

India Pharmaceutical Trade Intelligence

$179.9M171 Suppliers98 CountriesHS 30049099

ExportsIndia → LEBANON41.8%India → CANADA18.3%

ImportsGERMANY → India$14.0B BELGIUM → India$17.4M

Sandoz Private Limited — Apixaban Exporter #4 | $15.6M Trade Value | TransData Nexus | TransData Nexus

Sandoz Private Limited — Apixaban Exporter Profile

Indian Pharmaceutical Exporter · #4 for Apixaban · $15.6M export value · DGFT Verified

Sandoz Private Limited is the #4 Indian exporter of Apixaban with $15.6M in export value and 500 verified shipments. Sandoz Private Limited holds a 8.7% market share in Apixaban exports across 8 countries. The company exports 25 pharmaceutical products worth $159.4M across 15 therapeutic categories.

Sandoz Private Limited — Apixaban Export Profile: Buyers & Destinations

Sandoz Private Limited Apixaban export treemap — buyers and destination countries | TransData Nexus

Where Does Sandoz Private Limited Export Apixaban?

Country	Value	Shipments	Share
MALTA	$8.9M	341	71.3%
NETHERLANDS	$2.7M	96	21.6%
BRAZIL	$716.0K	39	5.7%
THAILAND	$125.8K	10	1.0%

Who Are the Top Buyers of Apixaban from Sandoz Private Limited?

Buyer	Country	Value	Orders
LEK PHARMACEUTICALS D.D., VAT MALTA	MALTA	$3.0M	150
EXPRESS TRAILERS LTD.	MALTA	$2.4M	64
SANDOZ B.V.	NETHERLANDS	$2.0M	72
EXPRESS TRAILERS LIMITED WAREHOUSE 1	MALTA	$1.2M	36
EXPRESS TRAILERS LTD WAREHOUSE 1 &	MALTA	$909.5K	36
SANDOZ B V	NETHERLANDS	$674.2K	24
SANDOZ DO BRASIL IND FARMACEUTICA	BRAZIL	$479.9K	24
LEK PHARMACEUTICALS D.D. VAT MALTA	MALTA	$340.0K	12
EXPRESS TRAILERS LTD	MALTA	$313.8K	21
LEK PHARMACEUTICALS DD	MALTA	$295.4K	8

Sandoz Private Limited supplies Apixaban to 25 buyers globally. The largest buyer is LEK PHARMACEUTICALS D.D., VAT MALTA (MALTA), followed by EXPRESS TRAILERS LTD. (MALTA) and SANDOZ B.V. (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Apixaban Formulations Does Sandoz Private Limited Export?

Product Description / Formulation	Value	Shipments
Material No. - 44100520 APIXABAN SDZ 5MG	$1.9M	50
MATERIAL NO. - 44100520 APIXABAN SDZ 5MG56FCT GB	$678.1K	15
MATERIAL NO - 44100520 APIXABAN SDZ 5MG56FCT GB	$617.9K	16
APIXABAN SDZ 5MG 56FCT GB MATERIAL NO. -44100520	$571.0K	13
Material No. - 44100520 APIXABAN SDZ 5MG56FCT GB	$550.0K	11
Material No. - 44100462, APIXABAN SDZ 5M	$479.7K	18
Material No. - 44100462 APIXABAN SDZ 5MG	$473.7K	16
MATERIAL NO-44100520 APIXABAN SDZ 5MG 56FCT GBPCS	$408.0K	21
Material No.-44100462, APIXABAN SDZ 5MG	$395.2K	14
Material No.-44100193, APIXABAN SDZ 5MG	$392.9K	8

Sandoz Private Limited exports 139 distinct Apixaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is Material No. - 44100520 APIXABAN SDZ 5MG with 50 shipments worth $1.9M.

How Does Sandoz Private Limited Compare to Nearest Apixaban Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
3	INTAS PHARMACEUTICALS LIMITED	$18.7M	436	9	$42.8K
2	APOTEX RESEARCH PRIVATE LIMITED	$18.1M	361	2	$50.0K
4	SANDOZ PRIVATE LIMITED ★	$15.6M	500	8	$31.2K
5	ZYDUS LIFESCIENCES LIMITED	$8.1M	194	11	$41.7K
1	MACLEODS PHARMACEUTICALS LTD	$4.3M	85	9	$50.0K

Sandoz Private Limited ranks #4 among 171 Indian Apixaban exporters. Average shipment value of $31.2K compared to the market average of $497.1K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and APOTEX RESEARCH PRIVATE LIMITED.

Which Indian Ports Ship Apixaban Exports?

Port	Shipments	% Share
SAHAR AIR	724	16.1%
SAHAR AIR CARGO ACC (INBOM4)	674	15.0%
DELHI AIR CARGO ACC (INDEL4)	607	13.5%
DELHI AIR	364	8.1%
MUNDRA SEA	146	3.3%
Bombay Air	134	3.0%
JNPT/ NHAVA SHEVA SEA	131	2.9%
AHEMDABAD AIR ACC (INAMD4)	129	2.9%

Geopolitical & Trade Policy Impact on Sandoz Private Limited's Apixaban Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Sandoz Private Limited. The escalation of conflicts in West Asia, particularly between Israel and Iran, has disrupted vital trade corridors such as the Red Sea and the Strait of Hormuz. These disruptions have led to increased shipping costs and extended transit times, impacting the timely delivery of pharmaceutical products. The Pharmaceuticals Export Promotion Council of India (Pharmexcil) has warned that prolonged disruptions could result in potential losses of up to ₹5,000 crore for the industry. (timesofindia.indiatimes.com)

Conversely, the ongoing US-China trade tensions have prompted the United States to diversify its pharmaceutical supply chain, creating opportunities for Indian exporters. Sandoz's established presence and compliance with international quality standards position it favorably to capitalize on this shift. However, the company must navigate the complexities of the European Union's Falsified Medicines Directive, which imposes stringent regulations to prevent counterfeit medicines from entering the supply chain. Adherence to these regulations is crucial for maintaining access to the lucrative EU market.

Sandoz Private Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards is paramount for Sandoz Private Limited. The company adheres to guidelines set forth by the U.S. Food and Drug Administration (FDA), the World Health Organization (WHO), and the European Union's Good Manufacturing Practices (EU GMP). Maintaining these certifications ensures the quality and safety of its products, facilitating access to global markets.

The evolving regulatory environment necessitates continuous investment in quality assurance and compliance. Sandoz's commitment to these standards not only mitigates the risk of regulatory actions but also enhances its reputation as a reliable supplier in the competitive pharmaceutical export market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Apixaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Sandoz Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 500 individual customs records matching Sandoz Private Limited exporting Apixaban, covering 139 formulations to 9 countries via 25 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 98+ countries, 371+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Apixaban

Apixaban

Sandoz Private Limited — Apixaban Exporter Profile

Sandoz Private Limited — Apixaban Export Profile: Buyers & Destinations

Where Does Sandoz Private Limited Export Apixaban?

Who Are the Top Buyers of Apixaban from Sandoz Private Limited?

What Is India's Total Apixaban Export Value and How Much Does Sandoz Private Limited Contribute?

What Is the Average Shipment Value for Sandoz Private Limited's Apixaban Exports?

How Does Sandoz Private Limited Compare to Other Indian Apixaban Exporters?

What Apixaban Formulations Does Sandoz Private Limited Export?

Regulatory Requirements: Exporting Apixaban to Key Markets

Brazil — ANVISA

How Does Sandoz Private Limited Compare to Nearest Apixaban Exporters?

Which Indian Ports Ship Apixaban Exports?

What Other Cardiovascular Products Does Sandoz Private Limited Export?

Geopolitical & Trade Policy Impact on Sandoz Private Limited's Apixaban Exports

Sandoz Private Limited — Regulatory Compliance & Quality Standards

About Sandoz Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Apixaban Export Data from Sandoz Private Limited

Apixaban Stats

Company Overview

Top Products by Sandoz Private Limited

Related Analysis

Need Detailed Export Data?

Data Source